An analysis of genetic alterations in primary CRCs between African American and Caucasian patients showed elevated KRAS mutation rates in African American patients, as well as mutations of three genes (EPHA6, FLCN and HTR1F) only in African American CRC patients, although these mutations have a low frequency (3–6%) [8,38]. Here, KRAS is linked to colorectal carcinoma.